Nicolas Penel
Centre Oscar Lambret · Centre Oscar Lambret - France · Oscar Lambret Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nicolas Penel as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03793361 · Phase II Study of Regorafenib as Maintenance TherapyCentre Oscar Lambret · completed · Metastatic Soft Tissue Sarcoma · study director
- N/ANCT02867033 · National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)Centre Oscar Lambret · active not recruiting · Aggressive Fibromatosis · principal investigator
- N/ANCT02553954 · Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues (SkinAge).Centre Oscar Lambret · completed · Sarcoma · study chair
- Ph2NCT01900743 · Phase II Study of Regorafenib in Metastatic Soft Tissue SarcomaCentre Oscar Lambret · completed · Sarcoma · study director
- N/ANCT01650077 · Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI CriteriaCentre Oscar Lambret · completed · Soft Tissue Sarcoma · study director
- Ph2NCT01612481 · Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue SarcomaCentre Oscar Lambret · terminated · Soft Tissue Sarcoma, Lung Metastasis · principal investigator
- Ph1NCT01374620 · Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly PaclitaxelCentre Oscar Lambret · completed · Cancer · principal investigator
- Ph2NCT01303094 · Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue SarcomaCentre Oscar Lambret · completed · Soft Tissue Sarcoma, Uterine Sarcoma · principal investigator
- Ph2NCT01303497 · Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced AngiosarcomasCentre Oscar Lambret · completed · Angiosarcoma · principal investigator
- N/ANCT00921232 · Assessment of the Burden Within the Dyad Patient/CaregiverCentre Oscar Lambret · completed · Palliative Care · principal investigator
- Ph2NCT00874874 · Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by SurgeryCentre Oscar Lambret · completed · Sarcoma · principal investigator
- Ph2NCT00217607 · Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryUNICANCER · completed · Sarcoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:53 UTC. The ranking covers the 200 most relevant of 101 PubMed records, and a shared surname and initials can bring in a namesake. All 101 on PubMed
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.J Clin Oncol · 20202,449 citationsRCR 111.1
- Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.J Clin Oncol · 2008504 citationsRCR 12.9
- Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study.Ann Oncol · 2022408 citationsRCR 26.8
- Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.JAMA Oncol · 2018365 citationsRCR 12.0
- Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.Lancet Oncol · 2020276 citationsRCR 13.1
- Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.Lancet Oncol · 2019273 citationsRCR 10.7
- Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.Nat Med · 2022261 citationsRCR 15.7
- Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.Lancet Oncol · 2016242 citationsRCR 8.3
- 225 citationsRCR 7.1
- 201 citationsRCR 5.5